Blackhill Capital Portfolio holdings
Blackhill Capital invests mainly in stocks for high net worth individuals, families and charitable foundations. Cary Schwartz, its president and chief investment officer, founded it in 1988 after working at Goldman Sachs from 1969 to 1988. The firm takes a value approach, looking for large, well-run companies that put shareholders first, and it plans around a one-to-five-year time horizon with low turnover to keep taxes down.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$13.5M |
| 2 |
Microsoft
MSFT
|
+$24K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$11.3M |
| 2 |
Apple
AAPL
|
+$5.14M |
| 3 |
Walt Disney
DIS
|
+$3.93M |
| 4 |
Zoetis
ZTS
|
+$2.3M |
| 5 |
Williams-Sonoma
WSM
|
+$1.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 74.19% |
| 2 | Healthcare | 13.08% |
| 3 | Technology | 6.07% |
| 4 | Energy | 2.14% |
| 5 | Industrials | 2.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Williams-Sonoma
WSM
$29.9B
| $1.75B | 73.77% |
7,678,178
-6,100
| -0.1% | -$1.41M |
2013 Q2
53 quarters
|
|
2
Eli Lilly
LLY
$1.29T
| $168M | 7.08% |
145,121
| – | – |
2013 Q2
53 quarters
|
|
|
3
Apple
AAPL
$5.18T
| $77.3M | 3.26% |
232,200
-16,000
| -6% | -$5.14M |
2015 Q1
46 quarters
|
|
|
4
AbbVie
ABBV
$521B
| $57.3M | 2.42% |
219,110
-44,000
| -17% | -$11.3M |
2013 Q2
53 quarters
|
|
5
Caterpillar
CAT
$275B
| $48.2M | 2.03% |
59,500
| – | – |
2013 Q2
53 quarters
|
|
|
6
Energy Transfer Partners
ET
$66.8B
| $44.5M | 1.88% |
2,252,500
+652,500
| +41% | +$13.5M |
2025 Q3
4 quarters
|
|
|
7
Microsoft
MSFT
$3.89T
| $33.9M | 1.43% |
66,102
+52
| +0.1% | +$24K |
2017 Q3
36 quarters
|
|
8
NVIDIA
NVDA
$3.93T
| $32M | 1.35% |
139,950
| – | – |
2023 Q4
11 quarters
|
|
9
Merck
MRK
$364B
| $24.5M | 1.03% |
168,857
| – | – |
2013 Q2
53 quarters
|
|
10
Abbott
ABT
$188B
| $17.6M | 0.74% |
177,930
| – | – |
2013 Q2
53 quarters
|
|
11
Bristol-Myers Squibb
BMY
$130B
| $17.2M | 0.72% |
275,364
| – | – |
2015 Q1
46 quarters
|
|
12
Johnson & Johnson
JNJ
$688B
| $17M | 0.72% |
64,187
| – | – |
2015 Q1
46 quarters
|
|
13
Mastercard
MA
$576B
| $11M | 0.46% |
20,000
| – | – |
2017 Q3
36 quarters
|
|
14
Berkshire Hathaway Class B
BRK.B
$1.26T
| $10.6M | 0.45% |
21,234
-3
| -0% | -$1.51K |
2013 Q2
53 quarters
|
|
15
Amazon
AMZN
$2.88T
| $9.11M | 0.38% |
36,580
| – | – |
2016 Q4
39 quarters
|
|
|
16
Walt Disney
DIS
$205B
| $6.62M | 0.28% |
63,100
-38,400
| -38% | -$3.93M |
2015 Q1
46 quarters
|
|
17
Procter & Gamble
PG
$394B
| $6.52M | 0.27% |
44,871
| – | – |
2013 Q2
53 quarters
|
|
18
Alphabet (Google) Class C
GOOG
$3.6T
| $6.02M | 0.25% |
17,660
| – | – |
2016 Q1
42 quarters
|
|
19
Alphabet (Google) Class A
GOOGL
$3.64T
| $5.5M | 0.23% |
15,980
| – | – |
2015 Q3
44 quarters
|
|
20
Berkshire Hathaway Class A
BRK.A
$1.26T
| $4.48M | 0.19% |
6
| – | – |
2013 Q2
53 quarters
|
|
21
Enterprise Products Partners
EPD
$82.6B
| $3.84M | 0.16% |
107,704
| – | – |
2013 Q2
53 quarters
|
|
22
Zimmer Biomet
ZBH
$19.5B
| $3.74M | 0.16% |
42,079
| – | – |
2013 Q2
53 quarters
|
|
23
Kimberly-Clark
KMB
$67.2B
| $2.83M | 0.12% |
29,000
| – | – |
2013 Q2
53 quarters
|
|
|
24
Zoetis
ZTS
$34.1B
| $2.62M | 0.11% |
37,546
-30,750
| -45% | -$2.3M |
2013 Q2
53 quarters
|
|
25
Chevron
CVX
$429B
| $2.36M | 0.1% |
11,550
| – | – |
2013 Q2
53 quarters
|
|
Similar funds
Blackhill Capital's Q3 2026 Portfolio in Review
As of Q3 2026, Blackhill Capital held 47 positions worth $2.37B, down 1.6% from $2.41B the previous quarter. Its ten largest holdings account for 95% of the portfolio.
Trading was light in Q3 2026: portfolio turnover was 4.3%. Blackhill Capital opened no new positions and exited 2, leaving the 47-position portfolio largely intact.
By sector, the portfolio is most concentrated in Consumer Discretionary at 74% of assets, down from 75% a quarter earlier, followed by Healthcare and Technology.
- Blackhill Capital added most to Energy Transfer Partners in Q3 2026, an estimated $13.5M increase.
- Blackhill Capital's biggest Q3 2026 reduction was AbbVie, cutting an estimated $11.3M.
- Blackhill Capital fully exited Weyerhaeuser in Q3 2026, selling an estimated $628K.
- Blackhill Capital's ten largest holdings make up 95% of its $2.37B portfolio in Q3 2026.
- Blackhill Capital opened 0 new positions and closed 2 in Q3 2026.
- Blackhill Capital's portfolio value fell 1.6% quarter-over-quarter to $2.37B.
Based on Blackhill Capital's 13F filing for Q3 2026, filed 13 Nov 2026.